Allopeptide-pulsed dendritic cells and composite tissue allograft survival

Microsurgery

Volumn 27, Issue 2, 2007, Pages 105-111

  Nguyen, Vu T ^a,b   Taieb, Aurele ^a,b   Sacks, Justin M ^a,b   Unadkat, Jignesh V ^a,b   Clavijo, Julio A ^a,b   Kim, Haena ^a,b   Feili Hariri, Maryam ^a,b   Lee, W P Andrew ^a,b,c  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; PEPTIDE DERIVATIVE; THYMOCYTE ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; BONE MARROW; CLINICAL PROTOCOL; COHORT ANALYSIS; COMPOSITE GRAFT; CONTROLLED STUDY; DENDRITIC CELL; GRAFT REJECTION; GRAFT SURVIVAL; HINDLIMB; IMMUNE DEFICIENCY; MOUSE; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RAT; RECIPIENT; T LYMPHOCYTE; TRANSPLANTATION TOLERANCE; VASCULARIZATION;

ANIMALS; BONE MARROW CELLS; DENDRITIC CELLS; FEMUR; GRAFT REJECTION; GRAFT SURVIVAL; MALE; PEPTIDES; RATS; RATS, INBRED LEW; RATS, INBRED WF; TRANSPLANTATION CONDITIONING; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 33947170905     PISSN: 07381085     EISSN: 10982752     Source Type: Journal    
DOI: 10.1002/micr.20314     Document Type: Article

References (26)

1. Baumeister S, Kleist C, Dohler B, Bickert B, Germann G, Opelz G. Risks of allogeneic hand transplantation. Microsurgery 2004;24:98-103.
2. Fuchimoto Y, Huang CA, Yamada K, Shimizu A, Kitamura H, Colvin RB, Ferrara V, Murphy MC, Sykes M, White-Scharf M, Neville DM Jr., Sachs DH. Mixed chimerism and tolerance without whole body irradiation in a large animal model. J Clin Invest 2000;105: 1779-1789.
3. Huang CA, Fuchimoto Y, Scheier-Dolberg R, Murphy MC, Neville DM Jr., Sachs DH. Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model. J Clin Invest 2000;105:173-181.
4. Janczewska S, Interewicz B, Ziolkowska A, Majewski T, Olszewski WL, Lukomska B. Rapid reconstitution of a lymphoid population of lethally irradiated rats following vascularized bone marrow transplantation is associated with engraftment of donor and stimulation of host hematopoietic cells. Transplant Proc 2000;32:1416-1418.
5. Coates PT, Thomson AW. Dendritic cells, tolerance induction and transplant outcome. Am J Transplant 2002;2:299-307.
6. Garrovillo M, Ali A, Depaz HA, Gopinathan R, Oluwole OO, Hardy MA, Oluwole SF. Induction of transplant tolerance with immunodominant allopeptide-pulsed host lymphoid and myeloid dendritic cells. Am J Transplant 2001;1:129-137.
7. Chowdhury NC, Saborio DV, Garrovillo M, Chandraker A, Magee CC, Waaga AM, Sayegh MH, Jin MX, Oluwole SF. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide. Transplantation 1998;66:1059-1066.
8. Buttemeyer R, Jones NF, Min Z, Rao U. Rejection of the component tissues of limb allografts in rats immunosuppressed with FK-506 and cyclosporine. Plast Reconstr Surg 1996;97:139-148. Discussion 149-151.
9. Chen-Woan M, Delaney CP, Fournier V, Wakizaka Y, Murase N, Fung J, Starzl TE, Demetris AJ. In vitro characterization of rat bone marrow-derived dendritic cells and their precursors. J Leukoc Biol 1996;59:196-207.
10. Lee WP, Yaremchuk MJ, Pan YC, Randolph MA, Tan CM, Weiland AJ. Relative antigenicity of components of a vascularized limb allograft. Plast Reconstr Surg 1991;87:401-411.
11. Ciancio G, Miller J, Garcia-Morales RO, Carreno M, Burke GW 3rd, Roth D, Kupin W, Tzakis AG, Ricordi C, Rosen A, Fuller L, Esquenazi V. Six-year clinical effect of donor bone marrow infusions in renal transplant patients. Transplantation 2001;71:827-835.
12. Fu F, Li Y, Qian S, Lu L, Chambers F, Starzl TE, Fung JJ, Thomson AW. Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation 1996;62: 659-665.
13. Chowdhury NC, Murphy B, Sayegh MH, Jin MX, Roy DK, Hardy MA, Oluwole SF. Acquired systemic tolerance to rat cardiac allo-grafts induced by intrathymic inoculation of synthetic polymorphic MHC class I allopeptides. Transplantation 1996;62:1878-1882.
14. Sayegh MH, Perico N, Imberti O, Hancock WW, Carpenter CB, Remuzzi G. Thymic recognition of class II major histocompatibility complex allopeptides induces donor-specific unresponsiveness to renal allografts. Transplantation 1993;56:461-465.
15. Cober SR, Randolph MA, Lee WP. Skin allograft survival following intrathymic injection of donor bone marrow. J Surg Res 1999;85:204-208.
16. Oluwole SF, Chowdhury NC, Ingram M, Garrovillo M, Jin MX, Agrawal S. Mechanism of acquired thymic tolerance induced by a single major histocompatibility complex class 1 peptide with the dominant epitope: Differential analysis of regulatory cytokines in the lymphoid and intragraft compartments. Transplantation 1999;68: 418-429.
17. Siemionow M, Ulusal BG, Ozmen S, Ulusal AE, Ozer K. Composite vascularized skin/bone graft model: A viable source for vascularized bone marrow transplantation. Microsurgery 2004;24:200-206.
18. Millan MT, Shizuru JA, Hoffmann P, Dejbakhsh-Jones S, Scandling JD, Grumet FC, Tan JC, Salvatierra O, Hoppe RT, Strober S. Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation. Transplantation 2002;73:1386-1391.
19. Rao AS, Shapiro R, Cony R, Dodson F, Abu-Elmagd K, Pham S, Jordon M, Salgar S, Zeevi A, Rastellini C, Ostrowski L, Aitouche A, Keenan R, Reyes J, Griffith B, Starzl TE, Fung JJ. Immune modulation in organ allograft recipients by single or multiple donor bone marrow infusions. Transplant Proc 1999;31:700-701.
20. Stewart FM, Zhong S, Lambert JF, Col vin GA, Abedi M, Dooner MS, McAuliffe CI, Wang H, Hsieh C, Quesenberry PJ. Host marrow stem cell potential and engraftability at varying times after low-dose whole-body irradiation. Blood 2001;98:1246-1251.
21. Wood ML, Monaco AP, Gozzo JJ, Liegeois A. Use of homozygous allogeneic bone marrow for induction of tolerance with antilymphocyte serum: Dose and timing. Transplant Proc 1971;3:676.
22. Ricordi C, Karatzas T, Nery J, Webb M, Fernandez L, Selvaggi G, Garcia R, Goldberg M, Schiff E, Olson L, Ruiz P, Esquenazi V, Miller J, Tzakis AG. Effect of timing of donor bone marrow infusions on liver allograft survival. Transplant Proc 1997;29:1186.
23. Benichou G, Valujskikh A, Heeger PS. Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice. J Immunol 1999;162:352.
24. Vella JP, Spadafora-Ferreira M, Murphy B, Alexander SI, Harmon W, Carpenter CB, Sayegh MH. Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction. Transplantation 1997;64: 795.
25. Valujskikh AD, Matesic D, Gilliam A, Anthony D, Haqqi TM, Heeger PS. T cells reactive to a single immunodominant self-restricted allopeptide induce skin graft rejection in mice. J Clin Invest 1998;101:1398.
26. Phillips NE, Greiner DL, Mordes JP, Rossini AA. Costimulatory blockade induces hyporesponsiveness in T cells that recognize alloantigen via indirect antigen presentation. Transplantation 2006;82: 1085-1092.